Sunday, September 13, 2026

Hydrofluoric Acid & Lithium-Ion Battery

Hydrofluoric Acid Exposure from Lithium-Ion Battery Fires: Toxicology, Presentation, and Management

Hydrofluoric Acid Exposure from Lithium-Ion Battery Fires: Toxicology, Presentation, and Management


Clinical Overview and Mechanism

  • Pathophysiology of Lithium-Ion Battery Fires:
    • Thermal runaway and combustion of lithium-ion batteries produce hydrofluoric acid (HF) vapor and other toxic fluorinated gaseous compounds.
    • The weak acid paradox: HF has a relatively low dissociation constant compared to strong mineral acids, remaining primarily in an un-ionized state.
    • Deep tissue penetration: The non-ionized HF molecule readily penetrates lipid-rich skin barriers and mucous membranes, diffusing deeply into subcutaneous tissues before full dissociation occurs.
    • Fluoride ion toxicity: Once dissociated, free fluoride ions avidly bind divalent cations, sequestering physiological calcium (Ca2+) and magnesium (Mg2+) to precipitate insoluble calcium fluoride (CaF2) and magnesium fluoride (MgF2).
    • Cellular destruction: Depletion of cellular calcium triggers cellular necrosis, liquefactive tissue destruction, and profound nerve stimulation.

Clinical Presentation and Hallmarks

  • Hallmark Symptom:
    • Severe, throbbing pain that is distinctly out of proportion to the initial physical appearance of the burn or cutaneous exposure.
    • Due to delayed cellular injury, burns may initially appear as mild erythema or completely normal skin before progressing to deep, painful liquefaction necrosis.
  • Mucosal and Inhalation Manifestations:
    • Inhalation of combustion fumes causes acute upper airway irritation, mucosal burning, rhinorrhea, cough, and stridor.
    • Lower respiratory tract injury can rapidly progress to chemical pneumonitis, bronchospasm, and non-cardiogenic pulmonary edema.
  • Systemic Toxicology Risks:
    • Significant exposures lead to rapid systemic fluoride absorption.
    • Severe electrolyte derangements: profound hypocalcemia, refractory hypomagnesemia, and life-threatening hyperkalemia (triggered by fluoride-induced inhibition of sodium-potassium ATPase).
    • Cardiovascular collapse: QTc prolongation, intractable ventricular arrhythmias (ventricular fibrillation, torsades de pointes), and cardiac arrest.

Responder Safety and Decontamination Protocols

  • Personal Protective Equipment (PPE):
    • Standard examination gloves (nitrile or latex) DO NOT provide adequate barrier protection against hydrofluoric acid penetration.
    • First responders and healthcare personnel must wear dedicated chemical-resistant gloves (heavy nitrile, butyl, or neoprene) and impervious gowns.
    • Appropriate respiratory protection (Self-Contained Breathing Apparatus [SCBA] in the field; acid-gas respirators in enclosed spaces) is mandatory during battery fire operations and initial patient handling to prevent secondary inhalation injury.
  • Decontamination:
    • Immediate removal and bagging of all contaminated clothing and personal effects.
    • Copious irrigation of affected skin and eyes with water or physiological saline.

Medical Management and Antidotal Therapy

  • Primary Antidote Principle:
    • Calcium administration neutralizes free fluoride ions by forming inert calcium fluoride complexes, arresting ongoing tissue destruction and correcting life-threatening electrolyte shifts.
  • Cutaneous Exposure Treatment:
    • Topical Calcium Gluconate Gel: Apply 2.5% calcium gluconate gel generously to the exposed area, massaging it continuously into the skin until pain resolves.
    • Compounding alternative: If commercial gel is unavailable, mix 3.5 grams of calcium gluconate powder into 100 mL of water-soluble surgical lubricant, or mix 10 mL of 10% calcium gluconate with 30 mL of surgical lubricant.
  • Inhalation Exposure Treatment:
    • Nebulized Calcium Gluconate: Administer nebulized 2.5% calcium gluconate solution promptly to neutralize inhaled acid fumes in the respiratory tree.
    • Preparation: Mix 1.5 mL of 10% calcium gluconate with 4.5 mL of sterile normal saline for nebulization.
    • Provide humidified supplemental oxygen and monitor for acute airway compromise.
  • Systemic Toxicity and Resuscitation:
    • Continuous cardiac monitoring and baseline 12-lead ECG.
    • Urgent laboratory panel: serial ionized calcium, magnesium, potassium, and renal function.
    • Intravenous Calcium: Administer intravenous calcium gluconate (or calcium chloride via central venous access) to treat hypocalcemia and widen QTc intervals.
    • Magnesium Replenishment: Aggressively correct concurrent hypomagnesemia using intravenous magnesium sulfate.

High-Yield Lecture Takeaways

  • Lithium-ion battery fires generate dangerous levels of hydrofluoric acid (HF) and fluorinated compounds.
  • Suspect HF toxicity when a patient presents with excruciating pain out of proportion to burn appearance following battery fire smoke exposure.
  • Standard medical gloves do not protect healthcare workers from HF; specialized chemical-resistant PPE and respiratory protection are mandatory.
  • Calcium gluconate is the definitive antidote: use 2.5% topical gel for skin, nebulized 2.5% solution for inhalation, and intravenous calcium for systemic toxicity.
  • Always monitor for sudden, fatal electrolyte shifts (hypocalcemia, hypomagnesemia, and hyperkalemia) that can precipitate malignant ventricular arrhythmias.

References

  • Song C, Marano M, Lee R, Lee C, Ndubisi M, Elbahrawy M, Folarin A. 954 Hydrofluoric Acid Fumes Associated with Electric Vehicle Lithium Ion Battery Fires. Journal of Burn Care & Research. 2025;46(Supplement 1):S365. doi:10.1093/jbcr/iraf019.485
  • Larsson F, Andersson P, Blomqvist P, et al. Toxic fluoride gas emissions from lithium-ion battery fires. Scientific Reports. 2017;7:10018. doi:10.1038/s41598-017-09784-z
  • Keelan S, Murphy M, Abrahams M, Shelley O, Kennedy S. Hydrofluoric acid inhalation injury after electric bike battery fire. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026;118:424-427. doi:10.1016/j.bjps.2026.04.035

Diabetic Ketoacidosis Management

Diabetic Ketoacidosis: Treat Ketones, Not Just Glucose Diabetic Ketoacidosis: Treat Ketones, Not Just Glucose Diagnostic...